Purchase Order 68HE0B24P0285

Award Date 2/8/24
Potential Completion Date 3/15/24
Potential Value $52K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
3
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed-price purchase order for $277,750.00 to Illumina, Inc. to provide an Illumina NextSeq 550 Sequencing System with accessories, installation, and training. This contract supports the EPA's genomic sequencing and analysis capabilities. Illumina is a manufacturer of sequencing and array-based solutions for genetic and genomic analysis, and has previously provided similar equipment and services to...
This is a firm fixed price purchase order awarded by the Environmental Protection Agency's (EPA) Office of Research and Development to Illumina, Inc., a manufacturer of sequencing and array-based genomic analysis solutions. The contract, valued at $13,888.29, is for the provision of Illumina sequencing reagents and kits to support the agency's FY24 REICHMAN research programs focused on PFAS (per- and polyfluoroalkyl substances) and other scientific priorities. The award has a period of...
The U.S. Environmental Protection Agency (EPA) Office of Research and Development has awarded Illumina, Inc. a $16,198 firm fixed price purchase order for a MiSeq system basic service contract renewal, with a period of performance through October 23, 2025. This contract does not have a set-aside designation. Illumina is a manufacturer of genomic sequencing instruments and reagents that has previously received prime federal contracts and subcontracts from agencies such as the NIH, CDC, USDA,...
The Environmental Protection Agency (EPA) Office of Research and Development awarded Illumina, Inc. a firm fixed price purchase order worth $8,712.00 to move and re-install the Illumina MiSeq system. The contract has a completion date of March 20, 2024 and does not utilize a set-aside. Illumina is a manufacturer of sequencing and genomic analysis instruments and reagents that has previously supported genomic research and diagnostics for agencies like the National Institutes of Health (NIH),...
The Environmental Protection Agency's Office of Research and Development awarded Illumina, Inc., a manufacturer of genetic sequencing and analysis instruments, a firm fixed price purchase order for a service maintenance agreement on a NextSeq sequencing system. The agreement has a base period of performance through May 19, 2024, with two optional renewal years, for a potential total value of $113,698.00. Illumina has previously received prime contract awards from federal agencies such as the...
The Environmental Protection Agency Office of Research and Development awarded a $37,040.86 firm fixed price purchase order to Illumina, Inc. of San Diego, California for Illumina sequencing kits to support the agency's Pollution and Ecosystems Division. No set-aside provisions were included. Performance will occur in San Diego through May 2024. As a manufacturer and provider of sequencing and array-based solutions, Illumina will deliver its sample preparation and sequencing kits to support...
The Environmental Protection Agency (EPA) Office of Research and Development awarded a $18,757.60 firm fixed price purchase order to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents, for the repair of Illumina MiSeq instruments. This award does not have a set-aside designation. Illumina has previously received federal contracts from agencies such as the National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), and Department of...
This firm fixed-price purchase order contract was awarded by the Environmental Protection Agency (EPA) Office of Research and Development to Illumina, Inc. for the purchase of a MiSeq2 system and accessories. The total ceiling value of the contract is $145,486.21. The contract has no set-aside designation. Illumina, a for-profit manufacturer of sequencing and genomic analysis instruments and reagents, has previously been awarded prime federal contracts and sub-grants by other agencies such as...
The Environmental Protection Agency Office of Research and Development awarded a firm fixed price purchase order valued at twenty-two thousand sixty-five dollars and thirty-eight cents ($22,065.38) to Illumina, Inc. to provide an Illumina NextSeq 500/550 High Output Kit V2.5. The award references Federal Acquisition Regulation 25.104(a) for spare and replacement parts for equipment of foreign manufacture where domestic parts are unavailable. Performance will take place in San Diego, California...
This is a firm fixed price purchase order awarded by the U.S. Environmental Protection Agency's (EPA) Office of Research and Development to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $113,042.40 contract provides for maintenance services for the agency's HiSeq2500 and NextSeq500 sequencing instruments over a one-year period. No set-aside provisions were used. Illumina has a history of providing sequencing equipment and services to various federal agencies,...

The Environmental Protection Agency (EPA) Office of Research and Development awarded a firm fixed price purchase order to Illumina, Inc. for the supply of NovaSeq 6000 and NextSeq reagent kits. The contract has a potential value of $52,482.40 and a completion date of March 15, 2024. The contract does not have a set-aside designation. Illumina, a for-profit manufacturer of genomic analysis instruments and reagents, has previously provided similar sequencing products and services to support research and diagnostics across various federal agencies. The EPA's requirement is for brand name only reagents to support the agency's genomic sequencing activities at its research facilities over the next three years.

Generated 3/30/24, 11:32 AM